文献速递免疫规划传染病防控与疫情报告

马拉维Karonga地区家庭肺炎球菌携带:PCV13引入前后对比

Pneumococcal carriage in households in Karonga District, Malawi, before and after introduction of 13-valent pneumococcal conjugate vaccination.
PubMed 文献 · Vaccine · 2018-10-21

马拉维2011年引入PCV13(3+0程序),本研究比较Karonga农村地区2009-2011年(疫苗前)与2014年(疫苗后)家庭肺炎球菌携带情况。结果显示疫苗接种儿童及未接种年长儿童和母亲的疫苗型携带下降,但6周龄婴儿和PCV13不合格的1-4岁儿童携带持续,接种的1-4岁儿童非疫苗型携带增加。

要点

  • 疫苗后18周龄接种婴儿、1-4岁接种儿童、5-15岁未接种儿童及母亲的疫苗型携带均下降。
  • 6周龄婴儿和PCV13不合格的1-4岁儿童疫苗型携带未见下降。
  • 仅接种的1-4岁儿童非疫苗型携带增加,提示血清型替换迹象。

核心结论

  • 马拉维农村地区PCV13引入三年后,疫苗型肺炎球菌携带下降,但6周龄婴儿和PCV13不合格的1-4岁儿童携带持续,接种的1-4岁儿童出现血清型替换迹象。

研究设计与样本

  • 比较疫苗前(2009-2011年)和疫苗后(2014年)的横断面与纵向分析,对象为母婴对及家庭中<16岁成员,采集鼻咽拭子。
  • 疫苗前菌株用乳胶凝集分血清群和Quellung反应分血清型,2014年两步均用乳胶凝集。
  • 采用log-binomial回归计算携带率比,调整年龄、季节性和家庭构成。

主要发现

  • 疫苗前疫苗型携带率:6周龄婴儿11.4%、18周龄婴儿45.1%、1-4岁儿童28.2%、5-15岁儿童21.2%、母亲6.6%。
  • 疫苗后疫苗型携带调整患病率比:18周龄接种婴儿0.24(95%CI 0.08-0.75)、1-4岁接种儿童0.54(0.33-0.88)、5-15岁未接种儿童0.37(0.17-0.78)、母亲0.34(0.15-0.79)。
  • 6周龄婴儿调整患病率比1.07(0.38-3.02),PCV13不合格的1-4岁儿童0.84(0.53-1.33),均未见下降。
  • 非疫苗型携带仅在1-4岁接种儿童中增加,调整患病率比1.58(1.21-2.06)。

临床怎么用

  • 马拉维采用3+0程序(6、10、14周龄)接种PCV13,疫苗后三年疫苗型携带下降,但6周龄婴儿和PCV13不合格的1-4岁儿童携带持续。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Thirteen-valent pneumococcal conjugate vaccine (PCV13) was introduced in Malawi in November 2011 and is offered to infants at 6, 10 and 14 weeks of age as part of routine immunisation. PCV13 is expected to reduce vaccine type (VT) nasopharyngeal carriage, leading to reduced transmission and herd protection. METHODS: We compared pneumococcal carriage in rural Karonga District, Malawi, pre-vaccine in 2009-2011 and post-vaccine in 2014 using a combination of cross-sectional and longitudinal analyses. Nasopharyngeal swabs were collected from a cohort of mother-infant pairs and household members <16 years. Pneumococci from 2009 to 2011 were serogrouped using latex agglutination and serotyped by Quellung reaction. In 2014, latex agglutination was used for both steps. Carriage prevalence ratios using prevalence data from before and after vaccine introduction were calculated by log-binomial regression, adjusted for age, seasonality and household composition. Participating infants in 2014 received PCV13 as part of routine immunisation. RESULTS: VT carriage prior to PCV-13 introduction was 11.4%, 45.1%, 28.2%, 21.2% and 6.6% for 6-week old infants, 18-week old infants, children 1-4 years, children 5-15 years and mothers, respectively. After vaccine introduction, VT carriage decreased among vaccinated 18-week old infants (adjusted prevalence ratio 0.24 (95%CI 0.08-0.75)), vaccinated children 1-4 years (0.54 (0.33-0.88)), unvaccinated children 5-15 years (0.37 (0.17-0.78)) and mothers (0.34 (0.15-0.79)). No decrease in VT carriage was observed for 6-week old infants too young to be vaccinated (1.07 (0.38-3.02)) and PCV-13 ineligible children 1-4 years (0.84 (0.53-1.33)). Non-VT carriage increased only among vaccinated children 1-4 years (1.58 (1.21-2.06)). CONCLUSIONS: There is evidence of reduced VT pneumococcal carriage three years after vaccine introduction in this rural Malawian population with good vaccine coverage using a 3 + 0 schedule. However carriage was sustained among 6-week-old infants and PCV13 ineligible 1-4 year olds, and there was some indication of serotype replacement in vaccinated 1-4 year olds.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Heinsbroek E, Tafatatha T, Phiri A, et al. Pneumococcal carriage in households in Karonga District, Malawi, before and after introduction of 13-valent pneumococcal conjugate vaccination. Vaccine. 2018. PMID: 30352744. doi:10.1016/j.vaccine.2018.10.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。